SOCS1 gene expression is increased in severe pulmonary tuberculosis

Area of Science:

• Immunology
• Molecular Biology
• Infectious Diseases

Background:

• Cytokine signaling plays a crucial role in regulating immune responses.
• Suppressors of cytokine signaling (SOCS) molecules are key negative regulators of cytokine signaling.
• The role of SOCS in tuberculosis (TB) pathogenesis and disease progression requires further elucidation.

Purpose of the Study:

• To investigate the association between SOCS molecules and disease progression in patients with pulmonary tuberculosis.
• To examine the gene expression of SOCS1 and SOCS3 in relation to TB severity.

Main Methods:

• Peripheral blood mononuclear cells (PBMCs) and T cells were collected from pulmonary TB patients (n=33) and healthy endemic controls (n=15).
• Gene expression of Interferon-gamma (IFN-γ), SOCS1, and SOCS3 was quantified using RT-PCR.
• Cytokine levels (IL6, IL10) in PBMC supernatants were measured.
• Statistical analysis was performed using the Mann-Whitney test.

Main Results:

• Elevated levels of IL6 and IL10 were observed in TB patients compared to controls.
• SOCS1 mRNA expression was significantly increased in T cells of TB patients versus controls.
• Higher SOCS1 mRNA levels were found in PBMCs of patients with far advanced TB compared to moderately advanced TB.
• SOCS1 expression correlated with increased disease severity in pulmonary TB.

Conclusions:

• Increased SOCS1 levels are associated with greater disease severity in tuberculosis.
• SOCS1 may impede mycobacterial control by regulating IFN-γ immunity and being upregulated by IL6.
• These findings suggest a potential mechanism by which Mycobacterium tuberculosis evades host immune responses.